Back to Search Start Over

Determination of bioactive compounds, antioxidant and anticancer activities of Tuckeroo ( Cupaniopsis anacardioides ) fruits.

Authors :
Pham NMQ
Vuong QV
Sakoff JA
Bowyer MC
Le VA
Scarlett CJ
Source :
3 Biotech [3 Biotech] 2022 Oct; Vol. 12 (10), pp. 257. Date of Electronic Publication: 2022 Sep 03.
Publication Year :
2022

Abstract

This study aimed to determine the phytochemical, antioxidant, and anticancer activities of the crude extract and its fractions of Cupaniopsis anacardioides . The results showed that total phenolic content (TPC), their secondary metabolites (flavonoids-TFC; proanthocyanidins-TPro), and antioxidant activity were significantly different between the crude extract and its fractions. The butanol fraction (F3) had the highest levels of TPC, TFC, and TPro, followed by the crude extract, aqueous fraction (F4), dichloromethyl fraction (F2), and hexane fraction (F1). High-Pressure Liquid Chromatography (HPLC) analysis revealed 14 major bioactive compounds were identified in the C. anacardioides extract. Further analysis showed F3 fraction contained the highest levels of the major bioactive compounds, while F1 fraction had the lowest. A similar pattern was observed for antioxidant activities. The crude extract, F3 and F4 fractions were further tested for cytotoxicity against 10 cancer cell lines, including HT29 (colon); U87, SJG2 (glioblastoma); MCF-7 (Breast); A2780 (ovarian); H460 (lung); A431 (skin); Du145 (prostate); BE2-C (neuroblastoma); MIA PaCa-2 (pancreas); and one non-tumour-derived normal breast cell line (MCF10A). Except for Du145 (prostate), the crude extract, F3 and F4 fractions inhibited the cancer cell lines at 100 µg/mL, with F3 possessing greater activity against these cancer cell lines. Future studies are recommended to isolate and identify the major bioactive compounds of the F3 fraction, and further tested their impact against cancer cell lines. This could identify the potential of anticancer agents from C. anacardioides .<br />Competing Interests: Conflict of interestOn behalf of all authors, the corresponding author states that there is no conflict of interest.<br /> (© The Author(s) 2022.)

Details

Language :
English
ISSN :
2190-572X
Volume :
12
Issue :
10
Database :
MEDLINE
Journal :
3 Biotech
Publication Type :
Academic Journal
Accession number :
36068843
Full Text :
https://doi.org/10.1007/s13205-022-03314-z